HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases globally. The company is headquartered in Mountain View, California.
| Revenue (TTM) | $176.03M |
| Gross Profit (TTM) | $135.20M |
| EBITDA | $-62.63M |
| Operating Margin | -36.10% |
| Return on Equity | -111.40% |
| Return on Assets | -16.80% |
| Revenue/Share (TTM) | $4.78 |
| Book Value | $3.52 |
| Price-to-Book | 8.22 |
| Price-to-Sales (TTM) | 14.18 |
| EV/Revenue | 13.17 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 40.50% |
| Shares Outstanding | $86.24M |
| Float | $64.17M |
| % Insiders | 5.20% |
| % Institutions | 71.01% |
Volatility is currently expanding